Bayer Plans $2.2 Billion Drug Plant in New Albany, With About 600 Jobs

- Advertisement -

Bayer plans to invest $2.2 billion in a new pharmaceutical manufacturing site in New Albany, adding a large drug plant to the business park northeast of Columbus.

The company announced the project on October 2, 2026. Bayer says the campus is expected to create about 600 high-value jobs and about 1,500 construction jobs. The site is planned as a modular plant that will make both drug substances, the active ingredients in medicines, and finished drug products. Bayer says the first products will support its oncology, cardiovascular, and kidney-disease portfolio, for patients in the United States and abroad.

The timetable is long. Bayer expects the drug-substance module to begin operating in 2031, with a drug-product module planned for 2034. The company describes the project as a plan based on current assumptions. Its announcement includes a standard warning that timing, cost, and hiring can change.

Bayer chief executive Bill Anderson said the United States has long been a manufacturing base and innovation hub for the company, and that the site is meant to strengthen supply of medicines here and overseas. Sebastian Guth, global chief operating officer for Bayer Pharmaceuticals and president of Bayer in the United States, called the expansion a step to meet demand in the company’s fastest-growing pharmaceuticals market. The plant would sit alongside Bayer’s U.S. pharmaceuticals headquarters in Whippany, New Jersey, and existing sites in Pennsylvania, California, Massachusetts, and North Carolina.

The announcement follows more than $7 billion in U.S. pharmaceutical research and manufacturing spending by Bayer over the previous five years. The company has also said the U.S. share of its pharmaceuticals revenue has risen sharply since 2018, and that it wants to keep growing that business. Products cited in connection with the U.S. push include Kerendia, for chronic kidney disease, and Nubeqa, for prostate cancer.

New Albany has drawn several life-sciences manufacturers to the same business park. State and local officials have treated the Bayer project as a major international investment for Ohio. Any state tax credit would still have to go through the Ohio Tax Credit Authority. Until ground is broken and hiring lists are posted, the jobs and the dollar figure remain company projections, not a completed factory.

Next in Franklin County: Texas Roadhouse in Grove City: Friendly Service, Uneven Rolls, 2.5 Cacti

- Advertisement -